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PREFACE 
The present thesis is based on an interest in patients hospitalised because of community-acquired pneumonia. 
Many patients have pneumonia, and these patients represent an economic burden because of their large numbers, 
relatively long length of stay, rehospitalisation, and death. Nonetheless, pneumonia does not receive significant 
attention in Danish hospitals. Few studies have focused on physiotherapeutic and occupational therapeutic inter-
ventions for this group of patients. 
 
This thesis is based on the following papers: 
 
Melgaard, D.; Baandrup, U.; Bøgsted, M.; Bendtsen, M.D; Kristensen, M. T.: Early mobilisation of patients with 
community-acquired pneumonia reduces length of hospitalisation: a clinical intervention study. Physiotherapy 
Theory and Practice (Submitted) 
 
Melgaard, D.; Baandrup, U.; Bøgsted, M.; Bendtsen, M.D; Hansen, T.; The prevalence of oropharyngeal dys-
phagia in Danish patients hospitalised with community acquired pneumonia. Dysphagia (Accepted) 
 
Melgaard, D.; Baandrup, U.; Bøgsted, M.; Bendtsen, M.D; Hansen, T.: Rehospitalization and mortality after 
hospitalization for Orapharyngeal Dysphagia and Community-Acquired Pneumonia: a 1-year prospective fol-
low-up study. The Journals of Gerontology Series B (Submitted). 
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Abbreviations 
CAP  Community-acquired pneumonia 
CAS Cumulated Ambulation Score 
CCI Charlson Comorbidity Index  
CG Control group 
CI Confidence Interval 
COPD Chronic Obstructive Pulmonary Disease 
CURB65 Severity scores for community-acquired pneumonia 
EM Early mobilisation 
ICF International Classification of Functioning, Disability and Health 
ICU Intensive Care Unit 
IG Intervention group 
IQR Interquartile range 
LOS Length of stay 
MRS Modified Rankin Scale 
NMS New Mobility Score 
OD Oropharyngeal dysphagia 
SD  Standard deviation 
VVS-T Volume Viscosity Swallow Test 
30-s cst 30-second chair-stand test  
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ENGLISH SUMMARY 
Community-acquired pneumonia (CAP) is one of the most common causes of admission to Danish hospitals, and 
despite the existence of suitable methods of treatment, many people die every year from CAP. The elderly are 
the most common group affected by CAP, and the risk increases in men, nursing home residents, and physically 
weakened individuals. The most common treatment is antibiotics. The severity of the illness and the overall 
health of the patients are essential to determining whether the treatment will occur in the patients’ homes or 
through hospital admission. The numerous and frequent long admissions are a burden to the economy of the so-
ciety. In addition, the course of the illness has significant consequences for patients because they often become 
weakened and experience a decline in their ability to function over longer periods, thus making it critical to limit 
the disease course as early as possible. The majority of the patients admitted with CAP are elderly, and therefore, 
they often have other diseases and illnesses, and hence an increased risk of developing oropharyngeal dysphagia 
(OD). Untreated OD can result in repeated cases of pneumonia, dehydration, and unwanted weight loss.  
The objectives of this thesis were 1) to determine whether a standardised and structured effort in relation to early 
mobilisation can optimise the admission progress and 2) to determine the prevalence of OD in patients admitted 
with CAP and to identify the factors that influence readmission and mortality.  
The studies were performed in the Department of Respiratory Medicine in the North Denmark Regional Hospi-
tal, and patients who were admitted with CAP were included. 
In the winter of 2012/2013, 97 patients who were admitted with CAP were included in this study. Physiothera-
pists mobilised patients within 24 hours after their admission. Compared with a similar group of patients who 
were admitted in the winter of 2011/2012, the results showed that early mobilisation resulted in a reduction of 
admission by 1.5 days.  
In the winter of 2013/2014, 154 patients who were admitted with CAP were checked for OD, and 34.4% were 
found to have OD. Patients with CAP and OD had a significantly longer duration of admission and higher read-
mission frequency and mortality than those of patients with only CAP. The one-year mortality rate for patients 
with CAP and OD was 71.7% versus 19.8% for patients with CAP.   
This thesis supports the need for a standardised and systematic effort with regard to the early mobilisation of pa-
tients with CAP; similarly, an early report of OD in patients with CAP may serve as a foundation for a standard-
ised multisector effort with regard to OD. Such an effort could improve patients' quality of life, reduce the num-
ber of admissions and reduce the high mortality 
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DANSK RESUME 
Lungebetændelse er en af de hyppigst forekommende årsager til indlæggelse i Danmark og til trods for gode be-
handlingsmuligheder er der stadig hvert år mange danskere, der dør af lungebetændelse. Ældre mennesker får 
oftere lungebetændelse og der er desuden en øget risiko for at få lungebetændelse hvis man er mand, plejehjems-
beboer og i øvrigt fysisk svækket. Behandlingen er oftest medicinsk med antibiotika. Sygdommens sværhedsgrad 
og patientens almentilstand er afgørende for om behandlingen foregår i hjemmet eller under indlæggelse på hos-
pital. De mange, og ofte relativt lange indlæggelser er belastende for samfundsøkonomien. Sygdomsforløbene har 
desuden store konsekvenser for patenterne, da sygdommen ofte medfører, at de bliver svækkede og får faldende 
funktionsevne over en længere periode, og det er vigtigt at begrænse dette fald i funktionsevne så tidlig som muligt. 
En stor del af de patienter der bliver indlagt med lungebetændelse er ældre og har andre sygdomme, dermed øges 
risikoen for, at de har dysfagi. Ubehandlet dysfagi kan medføre gentagne lungebetændelser, dehydrering og uøn-
sket vægttab. 
Formålene med denne afhandling var 1) at belyse hvorvidt en standardiseret og struktureret indsats i forhold til 
tidlig mobilisering kunne optimere indlæggelsesforløbene, 2) at afdække prævalensen af dysfagi hos patienter der 
bliver indlagt med lungebetændelse samt beskrive hvilke faktorer der har indflydelse i forhold til genindlæggelser 
og mortalitet. 
Studierne blev gennemført på Lungemedicinsk afsnit, Regionshospital Nordjylland, og patienter, der blev indlagt 
på grund af lungebetændelse blev inkluderet. 
I vinteren 2012/13 blev der inkluderet 97 patienter, der var indlagt med lungebetændelse. De blev mobiliseret af 
fysioterapeuter inden for 24 timer efter indlæggelsen. Sammenholdt med en sammenlignelig gruppe patienter der 
var indlagt vinteren 2011/12 viste resultaterne at tidlig mobilisering medførte en reduktion i indlæggelsestiden på 
1,5 dag. 
I vinteren 2013/14 blev 154 patienter, der blev indlagt med lungebetændelse undersøgt for dysfagi og 34.4% havde 
dysfagi. Patienter med lungebetændelse og dysfagi havde en signifikant længere indlæggelsestid, højere genind-
læggelsesfrekvens og mortalitet end gruppen af patienter med lungebetændelse. Etårs mortaliteten for patienter 
med lungebetændelse og dysfagi var 71.7% versus 19.8% for patienter med lungebetændelse.  
 
Denne afhandling understøtter en standardiseret og systematisk indsats i forhold til tidlig mobilisering af patienter 
med lungebetændelse. En tidlig udredning af dysfagi hos patienter med lungebetændelse vil ligeledes kunne danne 
grundlag for en systematisk, tværsektoriel indsats i forhold til dysfagi og dermed højne patienternes livskvalitet, 
reducere antallet af indlæggelser og nedsætte den meget høje mortalitetsraten hos denne gruppe patienter. 
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1. INTRODUCTION 
Community-acquired pneumonia (CAP) remains a leading cause of mortality worldwide.  In Denmark, it is the 
fifth highest reason for acute admission 1 and the third highest reason for readmission 2.  Admission and readmis-
sion result in considerable clinical and economic burdens 3-7.  The prevalence among elderly patients is high, up 
to four times the prevalence in younger populations 8.  Elderly patients are more likely to be treated in inpatient 
settings.  A Dutch registry study has documented that 80% of patients with CAP aged 80-84 years were treated 
in an inpatient setting compared with 56% of patients aged 50-54 years 4. In the elderly, pneumonia may present 
with fewer respiratory symptoms but with delirium, and worsening of chronic confusion, and falls 9. The elderly 
also complain of fewer symptoms than younger patients 10.  In Denmark, the incidence of patients hospitalised 
with CAP increased from 288 per 100 000 person-years to 442 per 100 000 person-years from 1994 to 2003.  
Age, comorbidity, and male gender were prognostic factors for admission 11. 
Studies have documented that the length of stay (LOS) in the hospital increases with age 12,13.  A Danish study 
has reported a median LOS of 6 days for patients hospitalised with CAP in the age ≥ 65 years 14.   
The rate of readmission in patients with CAP is relatively high, and a Danish study has reported that 12.3% of 
patients are readmitted within 30 days after discharge 14.  These results are in line with international studies re-
porting a rehospitalisation rate for patients with CAP from 1% to 20% 6.  
The mortality rates in-hospital and within 30 days after discharge range from 0-18% and from 1% - 23%, respec-
tively, 6,15,16.  A Danish registry study including 11.332 patients aged ≥65 years has demonstrated an in-hospital 
mortality of 11.5% and a mortality of 8.6% within 30 days after discharge for patients with CAP 14. 
The economic burden and the costs to treat CAP requiring hospitalisation are high 7.  Only a few studies have 
presented the financial burden of CAP, but a Dutch registry study has found that the majority of costs are gener-
ated by the elderly, and 76% of the total CAP cost is related to patients aged 50 years and older.  The mean cost 
per CAP case treated in a general ward is approximately 5000 € 4. 
Validated national and international guidelines exist for the management of patients with CAP 17-19.  These 
guidelines focus on when to hospitalise the patient and the rapidity of the administration of the first antibiotic 
dose, but there is limited or no focus on the effect of early mobilisation, nutrition, and swallowing disorders.  
Studies show that compliance with these guidelines can reduce unnecessary hospitalisations, LOS, costs, and 
mortality 20,21.  A Danish study has found a lack of compliance with the national Danish guidelines, especially 
relating to mobilisation and nutritional status 22.  
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2. BACKGROUND 
 
2.1. DEFINITION 
CAP is defined as an acute respiratory tract illness acquired outside of hospitals.  CAP is associated with radio-
graphic shadowing in admission chest radiographs and clinical symptoms such as coughing, sputum production, 
pleuritic chest pain, fever, tachypnoea, and rales 19.   
 
 
2.2. INCIDENCE   
The incidence of adults hospitalised with CAP has increased during the past several decades 11,23.  The risk fac-
tors for CAP are age, male gender, a general decrease in functional level, and malnutrition 9,24.  The rate of dis-
charge for CAP increases with age.  An American study has reported 33.4 per 10.000 for the ages of 45-64 and 
189.0 per 10.000 for ages ≥ 65 years 12.  A Danish study has found an incidence rate of 127 per 10.000 for pa-
tients with CAP for ages ≥ 65 years 14.  
 
2.3. EARLY MOBILISATION 
Mobility is closely related to the functional level and CAP, and admission to the hospital is often followed by 
immobilisation during the hospitalisation and by an irreversible decline in the functional level and quality of life 
after discharge 25.  People of all ages are affected by being immobilised, but hospitalisation and immobilisation 
are especially major risks for older persons 26.  
More factors are associated with immobilisation and hospitalisation.  Muscle strength is reduced with age, and 
decreased muscle strength and muscle atrophy follow immobilisation 26,27.  Muscle strength decreases by 5% per 
day when there is no contraction, and the lower extremities are especially affected; for elderly people, this reduc-
tion affects the functional level within a short time 28.   
The respiratory system undergoes more changes with age.  The maximum inspiratory pressure decreases by up to 
25%, the transdiaphragmatic pressure decreases by 13%, and the maximum voluntary ventilation decreases by 
12% 24.  Muscle atrophy and a decrease in size in fast twitch fibres are likely explanations for the reduced dia-
phragmatic strength 24.  The level of exercise capacity is an individual variable that depends on age, fitness, and 
regular physical activity 24. 
Recovery is prolonged in elderly patients 9, and hospitalisation, which results in immobility, is followed by a loss 
of functional levels in 25-60% of the patients 29,30. 
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Several studies have documented the effects of the early mobilisation (EM) of patients in intensive care and sur-
gery units 31-36, but a systematic review has included only a single study documenting this effect in patients with 
CAP 37.  This multicentre study included 458 patients with CAP, and the patients were randomised to EM or 
standard care in different settings.  The study has shown that the patients in the EM group had a LOS in the hos-
pital decreased by an average of 1.1 days compared with the standard care group 38.  However, this study did not 
report data for the level of mobilisation during hospitalisation, and a study investigating these findings has, to 
our knowledge, not been conducted, despite recommendations.  
A Danish study has reported that the Danish guidelines are followed with respect to medical treatment but not to 
mobilisation to a chair and the assessment of functional levels 22.   
  
2.4. OROPHARYNGEAL DYSPHAGIA 
It is essential for humans to eat and drink, and dysphagia describes difficulties in meeting these basic needs.  
There are more definitions of dysphagia, and one is “difficulties moving food from the mouth to the stomach,” 39 
but the International Classification of Functioning, Disability, and Health (ICF) classifies swallowing as “func-
tions of clearing the food and drink through the oral cavity, pharynx and oesophagus into the stomach at an ap-
propriate rate and speed 40.  Eating and drinking is a daily activity that includes the additional phases pre-oral, 
oral, pharyngeal, and oesophageal phase 41.  
Dysphagia is divided into oropharyngeal and pharyngeal dysphagia.  Difficulties in the phases mentioned above 
may lead to impairment in eating or drinking.  The impairment can be addressed as a lack of safety and/or effi-
ciency, as illustrated in figure 1. 
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Figure 1: Nutritional and respiratory complications associated with oropharyngeal dysphagia in older patients.  
(Clave, 2012) 42 (by courtesy of Nestlé Healthcare)  
 
As illustrated in figure 1, OD can lead to lung infections, frailty, malnutrition, loss of quality of life, and finally, 
death.  
OD is highly prevalent in elderly patients, and the prevalence is 47% in frail elderly hospitalised for acute ill-
ness42.  As illustrated in figure 2, additional factors are associated with OD.  Loss of muscle mass, impaired den-
tal status, reduction of saliva production, and changes of the cervical spine all affecting swallowing function 43. 
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Figure 2: Factors associated with dysphagia in older persons. (Wirth, 2016) 43 (by courtesy of Clinical Interven-
tions in Aging) 
  
Only one study has documented a prevalence in patients with CAP, providing a value of 91.3% 44. 
OD is not mentioned in the Danish guidelines for CAP 45, but awareness of OD and its consequences is increas-
ing in Denmark.  In 2012, the Danish Patient Safety Authority published a recommendation for protocols for OD 
in hospitals and municipalities 46. The recommendation was based on the occurrence of several adverse events 
and a lack of screening, and the recommendation has led to the national clinical guidelines “National Clinical 
Guideline for Oropharyngeal Dysphagia”, published in 2015 47.  These guidelines recommend a systematic, clin-
ical assessment of OD.  In Denmark, OD is not systematically explored in patients with CAP.  
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3. AIMS  
On the basis of the described background, the overall aim of this study was to investigate the effect of early mo-
bilisation on patients with CAP and the influence of OD in relation to CAP.  
 
The specific aims were the following: 
 
Study I 
The primary aim was to evaluate whether the early mobilisation of patients with CAP reduces the LOS.  The 
secondary aims were to systematically document the level of mobilisation during hospitalisation, to evaluate the 
deaths during hospitalisation and within 30 days after discharge, and to assess the prevalence of rehospitalisation 
within 30 days after discharge. 
 
Study II 
The aim was to assess the prevalence of OD in Danish patients hospitalised with CAP.  The secondary aims were 
to identify the risk factors for OD in patients with CAP and to investigate the association of OD in patients with 
CAP and LOS, rehospitalisation within 30 days after discharge, mortality during hospitalisation, and mortality 
within 30 days after discharge.  The long-term effect of OD was investigated by reporting the frequency of 
rehospitalisation 180 and 360 days after discharge and the mortality rates 180 and 360 days after discharge.  
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4. MATERIALS 
All included patients  18 years old were diagnosed with CAP and hospitalised in the Department of Respiratory 
Medicine in the North Denmark Regional Hospital and were discharged from this department.   
Patients received their first antimicrobial dosage within a few hours after hospitalisation 19.  Pre-antibiotic expec-
torated sputum was used to specify the antibiotic treatment 48.  The medical treatments switched from intrave-
nous to oral treatments when the patients had no signs of ileus, and when they were clinically stable 19. Accord-
ing to current guidelines, patients are considered to be clinically stable when their pulse is < 100/min, their res-
piratory frequency is < 24/min, their temperature is < 38°C, their systolic blood pressure is > 90 mm Hg, and 
their blood saturation level is > 90% 19. 
The severity of the pneumonia was determined via the CURB-65 system, a validated index measuring the sever-
ity of pneumonia and predicting the mortality.  The CURB-65 score is a part of the initial standard assessment 
procedure performed by the physician and consists of five factors: confusion, urea, respiratory rate, blood pres-
sure, and age ≥65 years.  These five variables, each receiving a dichotomous one or zero score, are added to de-
termine an overall score from 0 to 5 49,50.  
The comorbidity was measured using the Charlson Comorbidity Index (CCI) 51,52, which consists of 19 disease 
groups, each with a significant mortality risk (e.g., cancer, Chronic Obstructive Pulmonary Disease (COPD), or 
myocardial infarction); a higher score indicates a higher risk.  The scores were summed to a score between 0 and 
31.  
 
Patients who received antibiotics orally and were clinically stable and independently mobile or had reached their 
habitual state of function were discharged 19.  
 
Rehospitalisation is defined as rehospitalisation because of any disease in the northern region of Denmark.  
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5. METHODS 
Study I: Early mobilisation of patients with CAP 
A controlled study with longitudinal follow-up was performed. Patients hospitalised with CAP in the Department 
of Respiratory Medicine at the North Denmark Regional Hospital in the period from 1st September 2012 to 28th 
February 2013 were consecutively included and mobilised within 24 hours from admission.  
A historical control group (CG) was matched with the intervention group (IG) at the case level according to gender, 
age (2 years), hospitalisation due to CAP in the same Department of Respiratory Medicine, and being discharged 
from this ward in the period between 1st September 2011 and 28th February 2012.   
The following demographic data were recorded from the National Patient Register: age, gender, admission date, 
discharge date, first acute rehospitalisation within 30 days after discharge, and mortality.  The following medical 
information was recorded from the electronic patient records: CRP, temperature, urea, respiratory rate, confusion, 
blood pressure at hospitalisation, time from admittance to initiation of antibiotic therapy, use of corticosteroids, 
and medication by discharge.  
For the IG, the Cumulated Ambulation Score (CAS) 53, the pre-hospital New Mobility Score (NMS) 54, and the 
30-second chair-stand test (30-s cst) 55-57 were scored at the first contact with the physiotherapist. The CAS and 
30-s cst were thereafter recorded daily during the hospitalisation.  
The CAS describes patient independence in three activities: 1) getting in and out of bed 2) sitting down and stand-
ing up from a chair, and 3) being able to walk with or without an appropriate walking aid.  The scores for each 
activity were combined to provide a daily score between 0 and 6, with 6 indicating basic mobility independence. 
The NMS was used to describe the patients’ pre-hospital functional level, and patients reported their walking 
ability indoors, outdoors, and during shopping one week before they were hospitalised. Each activity was scored 
from 0–3, and a cumulative score between 0 and 9 was calculated, with high scores indicating a high level of 
activity. 
The 30-s cst standardised test was performed, and patients were instructed to use the armrests.  The score was the 
number of completed chair stands in 30 seconds 56.  
A non-standard taxonomy for mobilisation was registered daily and used for setting goals: 0 = not able to be 
mobilised; 1 = moved from lying in bed to sitting in a chair or to standing beside the bed; 2 = walked 1 to 10 
metres; 3 = walked 11 to 20 metres; 4 = walked 21 to 35 metres; and 5 = walked 36 or more metres. Each level 
was with or without help from the physiotherapist. These data were not reported.  
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Three experienced physiotherapists who had received a training session in administering the tests mobilised the 
patients within 24 hours of hospitalisation. EM was defined as movement out of bed with a change from the 
horizontal to the upright position for at least 20 minutes that progressed during the entire hospitalisation.  Physio-
therapy was offered daily on weekdays.   
After every intervention, the physiotherapist recorded the result of the mobilisation, and a goal was set for the next 
intervention.  
Study II: OD in patients with CAP 
A cross-sectional study with longitudinal follow-up was conducted.  Patients hospitalised with CAP in the Res-
piratory Medicine Department in the North Denmark Regional Hospital from 1st September 2013 to 31st March 
2014 were included and tested for OD. 
Of the 170 patients enrolled in the study, seven were excluded because they were unable to communicate and 
thus were unable to participate in the test, and nine patients declined to participate in the study.  Thus, 154 pa-
tients were included in the study.  
Data were collected on the body mass index (BMI), circumference of the waist (2 cm above the navel), level of 
oral health, strength in both hands, circumference of the lower leg (15 cm above the lower edge of the patella), 
and circumference of the upper arm (lateral epicondyle + 10 cm).  The age, gender, admission date, discharge 
date, and first acute readmission within 30 days after discharge were recorded from the National Patient Regis-
ter.  
 
Frailty was indicated by the following parameters: functional level before hospitalisation as reported with the 
Modified Rankin Scale (MRS) 53, functional level at hospitalisation as assessed with Barthel-20 58-61, and comor-
bidity as computed with the CCI.  A diagnosis of dementia, admission from a nursing home, and handgrip 
strength measured using a Jamar dynamometer 62,63 was also part of the combination of factors illustrating frailty 
in this group of patients.   
 
OD was assessed using the Danish version of the clinical volume-viscosity swallow test (V-VST) 64,65 and was 
administered by experienced occupational therapists.  The test assesses different types of viscosity and different 
volumes and indicates the efficacy and safety of swallowing.  The bolus volumes were 5 ml, 10 ml, and 20 ml. 
The bolus viscosity was a liquid viscosity; nectar viscosity was achieved by adding 1.2 g of the thickener Re-
source ThickenUp (Nestlé HealthCare Nutrition) to 100 ml water, and pudding viscosity was achieved by adding 
6.0 g of the thickener Resource ThickenUp to 100 ml water.  Mineral water at a room temperature of 25 °C was 
used.  Boluses with each volume and viscosity were administered to the patients with a syringe during the test to 
ensure an accurate measurement of the volume.  Before the V-VST, a pulse oximeter was placed on the index 
finger, and baseline readings were measured before starting the test.  During the test, the following clinical signs 
of impaired efficacy were observed: impaired labial seal, oral or pharyngeal residue, and multiple swallows per 
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bolus.  The clinical signs of impaired safety of swallowing were also observed: changes in voice quality, cough-
ing, and a decrease in the oxygen saturation ≥3%, indicating silent aspiration.  The original Spanish version of 
V-VST has an 83.7% sensitivity and 64.7% specificity for bolus penetration into the larynx and a 100% sensitiv-
ity and 28.8% specificity for aspiration 64. 
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6. STATISTICS 
Statistical analyses were performed using Stata version 13.1 software (Stata Corporation, College Station, TX, 
USA).  Throughout the analyses, 95% confidence intervals (CI) are reported, and a P-value < 0.05 was consid-
ered to be significant. Descriptive statistics included the number and percentage of patients for categorical varia-
bles, and the mean (±SD) or median (interquartile range (IQR)) for continuous variables.  Differences between 
the two groups in the studies were analysed using Fisher’s exact test for categorical variables and two-sample t-
tests for continuous variables. Log-rank tests were applied to assess the differences in survival and rehospitalisa-
tion between the two groups in both studies. The Kaplan-Meier method was applied to estimate the mean LOS 
with discharge as the event and censoring for death. Z-tests were conducted to test for differences in the LOS 
between the two groups 63.     
 
Study I 
The distributions of some clinical variables were positively skewed, but the number of observations per group 
was sufficiently large to justify using the t-test without a log transformation.  
 
Study II 
To compare continuous frailty parameters between the two groups, age and gender-adjusted t-tests (ANCOVA) 
were conducted.  The suitability of these models was assessed by Q-Q plots of the residuals and scatter plots of 
the residuals versus the fitted values and to assess the homogeneity of the regression slopes, a visual inspection 
of scatter plots of the frailty parameter versus the covariate with regression lines for each group was performed.  
In some cases, models of the log-transformed frailty parameters were more suitable but did not alter the conclu-
sions, and because the untransformed parameters are easier to interpret, those parameters are reported in table 8.  
The associations between the dichotomous frailty parameters and the two groups were estimated as age- and 
gender-adjusted incidence rate ratios using modified Poisson regression with robust variance estimation 66. The 
variables of hand grip and BMI were so positively skewed that they are reported in table 12 and 13 with a me-
dian (IQR) and analysed with the Wilcoxon rank-sum test.  Even though the distributions of some of the other 
clinical variables were also positively skewed, the number of observations per group was sufficiently large to 
justify using the t-test without a log transformation.   
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7. ETHICS 
Study I: 
The study was registered with the Danish Data Protection Authority (2008-58-0028), conducted according to the 
Declaration of Helsinki 67 and approved by the local ethical committee. To mobilise patients early after admission 
is common practice in Denmark, and therefore, informed consent was not relevant. 
 
Study II: 
The study was presented to the North Denmark Region Committee on Health Research Ethics (N-20130058), but 
the committee responded that the study did not require the approval of the committee due to the fact testing for 
OD is common practice in Denmark.  The study was conducted according to the Declaration of Helsinki 67 and 
was approved by the Danish Data Protection Authority (2008-58-0028).  
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8. RESULTS 
Study I: Early mobilisation of patients with CAP 
In Study I, 111 consecutive patients were enrolled in the IG, and 14 patients were excluded because they were 
transferred to another department for further rehabilitation or they were transferred to the Intensive Care Unit 
(ICU). A historical CG was matched with the IG, and the patients in the IG and the CG were similar in age, gender, 
severity of pneumonia (CURB65), CCI, time from admittance to initiation of antibiotic therapy, use of corticoster-
oids and medication at discharge. In the IG, fewer patients had COPD (P = 0.044) as illustrated in table 1.   
 
Table 1: Baseline data, demographic, and clinical characteristics of patients with CAP 
 Intervention group (N=97) Control group (N=97) P-value 
Age 71.9 (±16.5) 71.9 (±16.5) 0.982 
≤49 10 (10.3%) 9 (9.3%)  
50-69 26 (26.8%) 26 (26.8%)  
70-79 26 (26.8%) 31 (32.0%)  
80- 35 (36.1%) 31 (32.0%) 0.872 
Gender 
Male 51 (52.6%) 51 (52.6%) 1.000 
CURB65    
Confusion 9 (9.3%) 15 (15.5%) 0.275 
Urea (carbamide >7  
Mmol/L) 
34 (35.1%) 31 (32.0%) 0.920 
Respiratory rate ≥  
30/min 
10 (10.4%) 6 (6.2%) 0.310 
Blood pressure <90mmHg syst or 
≤60 mmHg dias 
14 (14.6%) 18 (18.6%) 0.562 
≥ 65 years 72 (74.2%) 67 (69.1%) 0.524 
CURB65 score    
0 15 (18.1%) 16 (19.1%)  
1 29 (34.9%) 26 (30.9%)  
2 26 (31.3%) 30 (35.7%)  
3 13 (15.7%) 10 (11.9%)  
4 0 (0%) 1 (1.2%)  
5 0 (0%) 1 (1.2%)  
Unknown 14 (14.4%) 13 (13.4%) 0.839 
Comorbidity    
Congestive heart failure  10 (10.3%) 4 (4.1%) 0.163 
Cerebrovascular disease  11 (11.3%) 11 (11.3%) 1.000 
Dementia   4 (4.1%) 3 (3.1%) 1.000 
COPD 39 (40.2%) 54 (55.7%) 0.044 
CCI 4.6 (±2.0) 4.5 (±1.8) 0.910 
Time to antibiotic therapy (hours)  10.0 (±6.5) 10.0 (±7.69) 0.963 
Corticosteroids 53 (54.6%) 48 (49.5%) 0.566 
Medication by discharge 9.6 (±5.2) 9.5 (±6.3) 0.921 
Temperature by hospitalisation 38.1 (±0.9) 37.9 (±0.9) 0.197 
Data are reported as number (%) for categorical variables, and as mean and SD (±) for continuous variables. The p-values are 
from unpaired t-test for continuous variables and Fisher´s exact test for categorical variables. 14 patients in the IG and 13 
patients in the CG have incomplete CURB65. 
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Patients in the IG were discharged after an estimated mean of 5.0 days (CI: 4.1; 5.9), and patients from the CG 
after 6.5 days (CI: 5.1; 7.9). The difference was -1.5 (CI: -3.2; 0.2) days between the IG and the CG (P=0.077).   
From winter 2011/2012 to winter 2012/2013, the mean LOS for all patients in the department decreased from an 
average of 4.8 days to 4.7 days. This difference was clinically irrelevant and statistically non-significant, and 
therefore it was ignored. 
As presented in table 2, patients from the IG with a CURB65 score of 0-2 had a significant shorter LOS as com-
pared with those in the CG; for example, patients with a CURB65 score of 2 in the IG had an LOS of 5.0 versus 
8.1 in the CG (P=0.041). Patients in the IG with COPD had a significantly shorter LOS than those in the CG 
with COPD, with a mean of 2.05 (P=0.028) days. 
 
Table 2: Length of stay on the basis of CURB65 and COPD in patients with CAP 
Intervention group (n=83) Control group (n=84) 
CURB65 n LOS Mean Compliance n LOS Mean Diff (IG-CG) P-value 
0 15 3.6 
(2.2; 4.9) 
14 (93.3%) 16 4.3 
(3.2; 5.5) 
-0.8 
(-2.6; 1.0) 
0.381 
1 29 5.4 
(3.9; 6.9) 
25 (82.2%) 26 7.1 
(3.6; 10.6) 
-1.7 
(-5.5; 2.1) 
0.379 
2 26 5.0 
(4.0; 6.1) 
22 (84.6%) 30 8.1 
(5.3; 10.9) 
-3.1 
(6.1; 0.1) 
0.041 
3 13 8.9 
(5.4; 12.4) 
9 (69.2%) 10 7.1* 
(4.7; 9.5) 
1.8 
(-2,5; 6.0) 
0.419 
Total 83  70 (84.3%) 84    
COPD 39 4.3 
(3.5; 5.1) 
33 (84.6%) 54 6.4 
(4.7; 8.0) 
-2.1 
(-3.9; -0.2) 
0.028 
14 patients in the intervention group and 13 patients in the control group were not included in this table due to incomplete 
CURB65. *Two patients with a CURB65 score of respectively 4 and 5 included. Diff=difference in length of stay between 
intervention group and control group. Compliance=number of patients and percentage of patients undergoing early mobilisa-
tion. Z-tests were applied to test for differences in LOS between the two groups. 
In the IG, 59 of 97 patients reached basic mobility independence on the first day after admission; additionally, 16 
out of the 28 patients still hospitalised on day 4 also reached basic mobility independency on the first day after 
admission. In contrast, 4 out of the 5 patients who were still hospitalised on day 7 did not achieve independent 
mobility (table 3). 
 
 
Table 3:  Mobility on days 1, 4, and 7 in patients hospitalised with CAP 
 Day 1 Day 4 Day 7 
Total (N=97) Total (n=28) Total (n=5) 
Mob >20 min per day 80 (82.5%) 24 (85.7%) 2 (40.0%) 
CAS getting in and out of bed 
Unable to perform function with human 
assistance 
17 (17.5%) 5 (17.9%) 3 (60%) 
Required human assistance to perform 
function 
4 (4.1%) 2 (7.1%) 1 (20%) 
Did not require human assistance 76 (78.4%) 21 (75.0%) 1 (20%) 
CAS sitting down and standing up from chair 
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Unable to perform function with human 
assistance 
18 (18.6%) 6 (21.4%) 4 (80%) 
Required human assistance to perform 
function 
7 (7.2%) 0 (0%) 0 (0%) 
Did not require human assistance 72 (74.2%) 22 (78.6%) 1 (20%) 
CAS walking ability with an appropriate walking aid 
Unable to perform function with human 
assistance  
21 (21.6%) 9 (32.1%) 4 (80%) 
Required human assistance to perform 
function  
17 (17.5%) 3 (10.7%) 0 (0%) 
Required human assistance to perform 
function  
59 (60.8%) 16 (57.1%) 1 (20%) 
CAS total (min. 0, max. 6) 6 (4 - 6) 6 (4 - 6) 0 (0 - 3) 
CAS=6 59 (60.8%) 16 (57.1%) 1 (20%) 
 n=72 n=22 n=1 
Number of sit to stand in 30 seconds 7 (0-10) 8.5 (0-10.8) 0 (0-1) 
Data are presented as number (%), or as median (25-75%). 
 
Patients in the IG who could be mobilised out of bed for more than 20 minutes within 24 hours after hospitalisa-
tion had a shorter LOS (P=0.021) than those with a lower level of mobility (table 4). Similarly, patients who 
were independent in basic mobility activities on day 1 (CAS score=6) were discharged earlier (P=0.002) than 
those who were not. As illustrated in Table 4, the primary factors influencing whether a patient was inde-
pendently mobilised on day 1 appeared to be the functional level before hospitalisation (NMS) and a low 
CURB65 score compared with that of patients who were not early mobilised.  
 
 
Table 4:  LOS according to patient characteristics, early mobilisation, and basic mobility status for 
the intervention group    
   Mob < 24 h                                               P-value CAS = 6 at day 1
  
P-value 
 Yes 
n=80 
No 
n=17 
 Yes 
n=59 
No 
n=38 
 
Age 
<70 y 33 (41.3) 3 (17.6%) 0.097 29 (49.2%) 7 (18.4%) 0.003 
>70 y 47 (58.8) 14 (82.4%)  30 (50.9%) 31 (81.6%)  
Gender 
Male 44 (55.0%) 7 (41.2%) 0.423 34 (57.6%) 17 (44.7%) 0.298 
NMS 
NMS 0-8 30 (37.5%) 12 (75.0%) 0.011 13 (22.0%) 29 (78.4%) <0.001 
NMS 9 50 (62.5%) 4 (25.0%)  46 (78.0%) 8 (21.6%)  
CURB65 
0 14 (20.0%) 1 (7.7%)  13 (26.0%) 2 (6.1%)  
1 25 (35.7%) 4 (30.8%)  19 (38.0%) 10 (30.3%)  
2 22 (31.4%) 4 (30.8%)  15 (30.0%) 11 (33.3%)  
3 9 (12.9%) 4 (30.8%) 0.416 3 (6.0%) 10 (30.3%) 0.007 
LOS 
Days 4.4  
(3.6; 5.3) 
7.8  
(4.4; 8.8) 
0.017 3.8  
(2.9; 4.7) 
6.8  
(5.3; 8.2) 
0.001 
Data are reported as number (%) for categorical variables, and as mean and 95% CI for continuous variables. Independent t-
test for continues variables and Fisher´s exact test for categorical variables. Due to incomplete CURB65 10 patients mobi-
lised within 24 hours and 4 patients not mobilised within 24 hours were excluded. 9 patients with CAS=6 and 5 patients with 
CAS<6 were excluded due to incomplete CURB65. 
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As shown in table 5, four patients (4.1%) in the IG died during hospitalisation compared with seven patients 
(7.2%) in the CG (P=0.351). The mortality rate 30 days from discharge was 4 out of 93 patients (4.3%) in the IG 
versus 3 out of 90 patients (3.3%) in the CG (P=0.738). 
 
Table 5: All causes of mortality during hospitalisation and within 30 days for patients with CPAP 
 Intervention group Control group 
 Dead 
N=4 
(4.1%) 
Alive 
N=93 
(95.9%) 
Dead 
N=7 
(7.2%) 
Alive 
N=90 
(92.8%) 
Dead during hospitalisation 
Age 
<70 y 0 (0%) 36 (38.7%) 2 (28.6%) 33 (36.7%) 
≥70 y 4 (100%) 57 (61.3%) 5 (71.4%) 57 (61.3%) 
Gender 
Male 2 (50.0%) 49 (52.7%) 4 (57.1%) 47 (52.2%) 
NMS 
NMS 0-8 4 (100%) 38 (41.3%)   
NMS 9 0 (0%) 54 (58.7%)   
CURB65 
0 0 (0%) 15 (18.7%) 0 (0%) 16 (20.3%) 
1 0 (0%) 29 (36.3%) 1 (20.0%) 25 (31.7%) 
2 1 (33.3%) 25 (31.2%) 2 (40.0%) 28 (35.5%) 
3 2 (66.7%) 11 (13.8%) 2 (40.0%) 10 (12.7%) 
CCI 
 5.5±1 4.5±2.0 5.4±1.0 4.4±1.9 
Dead within 30 days after discharge 
 N=4 
(4.3%) 
N=89 
(95.7%) 
N=3 
(3.3%) 
N=87 
(96.7%) 
Age 
<70 y 0 (0%) 36 (40.5%) 1 (33.3%) 32 (36.8%) 
≥70 y  53 (59.6%) 2 (66.7%) 55 (63.2%) 
Gender     
Male 1 (25.0%) 48 (53.9%) 2 (66.7%) 45 (51.7%) 
NMS 
NMS 0-8 3 (75.0%) 35 (39.8%)   
NMS 9  53 (60.2%)   
CURB65 
0 0 15 (19.5%) 0 16 (21.1%) 
1 2 (66.7%) 27 (35.1%) 1 (33.3%) 24 (31.6%) 
2 0 25 (32.5%) 2 (66.7%) 26 (34.2%) 
3 1 (33.3%) 10 (13.0%) 0 10 (13.2%) 
CCI                                                           6.5 (±3.7) 4.4 (±1.9) 4.0 (±1.7) 4.5 (±1.9) 
Data are reported as number (%) for categorical variables, and as mean and SD (±) for continuous variables
 
In the IG, 19 out of 93 (20.4%) patients were rehospitalised within 30 days after discharge compared with 13 out 
of 90 (14.4%) in the CG (P=0.274), as shown in table 6. However, 5 of the patients in the IG were rehospitalised 
because of diseases other than lung-related diseases (e.g., aorta stenosis or cancer) compared with one patient in 
the CG who was rehospitalised because of pancreatitis.  
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Study II: OD in patients with CAP 
 
As presented in table 7, 154 patients were consecutively included in study II: 54.5% were male, the mean age 
was 77.4 (±11.5) years, and 34.4% (27.3; 42.3) of the sample was diagnosed with OD. In the group of patients 
over 70 years, 37.1% were diagnosed with OD. The patients with both OD and CAP were discharged after a 
mean of 10.6 days (8.8; 12.3) compared with 8.0 days (6.9; 9.1) (P=0.018) for patients with CAP alone.  Patients 
with both OD and CAP had a significantly poorer tooth status (P=0.049), oral hygiene (P=0.018), and BMI 
(P=0.005). 
 
 
 
 
 
Table 6: All causes of rehospitalisation within 30 days from discharge 
 Intervention group P-value Control group P-value 
   Rehospitalised 
N=19 (20.4%) 
Not  
rehospitalised 
N=74 (79.6%) 
 Rehospitalised 
N=13 (14.4%) 
Not 
 rehospitalised 
N=77 (85.6%) 
 
Age 
<70 y 6 (31.6%) 30 (40.5%)  6 (46.2%) 27 (35.1%)  
>70 y   0.600   0.537 
Gender 
Male 9 (47.4%) 40 (54.1%) 0.618 10 (76.9%) 37 (48.1%) 0.073 
NMS 
NMS 0-8 12 (66.7%) 26 (35.1%)     
NMS 9 6 (33.3%) 48 (64.9%) 0.018    
CURB65 
0 3 (15.8%) 12 (19.7%  4 (30.8%) 12 (18.2%)  
1 8 (42.1%) 21 (34.4%)  4 (30.8%) 12 (18.2%)  
2 6 (31.6%) 19 (31.2%)  5 (38.5%) 23 (34.9%)  
3 2 (10.5%) 9 (14.8%) 0.964 2 (15.4%) 8 (12.1%) 0.482 
CCI 
 4.5 
 (3.55; 5.39) 
4.5 
 (4.03; 4.99) 
 
0.939 
4.5 
 (3.42; 5.66) 
4.4 
 (4.00; 4.85) 
 
0.885 
COPD 
 10 (52.6%) 28 (37.8%) 0.299 7 (53.9%) 41 (53.3%) 1.000 
LOS 
Days 5.6  
 (3.8; 7.4) 
4.4  
 (3.6; 5.2) 
0.247 6.7  
 (4.3; 9.1) 
5.8  
 (4.4; 7.3) 
0.529 
Cause of rehospitalisation 
Pneumonia  
COPD 
14 (73.7%)   12 (92.3%)   
Other dis-
eases 
5 (26.3%)   1 (7.7%)   
Data are reported as number (%) for categorical variables, and as mean and 95% CI for estimated mean LOS. Unpaired t-
test for continuous variables and Fisher´s exact test for categorical variables. 13 patients in the intervention group and 11 
patients in the control group had incomplete CURB65. 
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Table 7: Baseline data, demographic, and clinical characteristics of patients with CAP and OD. 
 Patients with CAP and 
OD 
N=53 
34.4% 
Patients with CAP 
alone 
N=101 
65.6% 
P-
value 
Age (mean) 80.9 (10.6) 76.0 (11.6) 0.011 
<50 0 4  
50-69 7 19  
70-79 14 38  
80+ 32 40 0.075 
Point of origin 
House/apartment 36 (68.9%) 98 (97.0%)  
Nursing home 17 (32.1%) 3 (3.0%) >0.001 
Volume Viscosity Swallow Test 
Impaired safety 50 (94.3%)   
Impaired efficacy 44 (83.0%)   
CURB65 
Confusion (yes) 23 (45.1%) 13 (13.5%) >0.000 
Urea (carbamide>7 Mmol/L) 36 (70.6%) 40 (41.7%) 0.001 
Respiratory rate >30/min 8 (16.0%) 7 (7.3%) 0.149 
Blood pressure <90 mmHg syst 
or 
60  mmHg diast  
6 (11.8%) 15 (15.6%) 0.625 
65 years 48 (90.6%) 89 (88.1%) 0.789 
Use of oxygen   
Yes 4 (7.6%) 11 (10.9%)  
No 42 (79.3%) 85 (84.2%)  
Unknown 7 (13.2%) 5 (5.0%) 0.191 
Tooth status 
No dentures 14 (26.4%) 41(40.6%)  
Denture on upper jaw 7 (13.2%) 17 (16.8%)  
Denture on underjaw 0 (0%) 2 (2.0%)  
Dentures 25 (47.2%) 38 (37.6%)  
Unknown 7 (13.2%) 3 (3.0%) 0.049 
Oral hygiene 
2 times per day 24 (45.3%) 70 (69.3%)  
1 time per day 18 (34.0) 20 (19.8%)  
3-5 times per week 1 (1.9%) 4 (4.0%)  
1-2 times per week 1 (1.9%) 2 (2.0%)  
1 time per month 0 (0%) 0 (0%)  
Never 2 (3.8%) 1 (1.0%)  
Unknown 7 (13.2%) 4 (4.0%) 0.018 
Weight 64.8 kg (15.2) 73.6 kg (22.0) 0.023 
Height 169.15 cm (9.6) 167.5 cm (8.7) 0.586 
BMI 22.7 (5.1) 26.1 (6.9) 0.005 
Waist-line 101.5 (13.3) 106.0 (19.2) 0.124 
Medication by discharge 9.4 (4.3) 10.2 (11.7) 0.573 
Temperature by hospitalisa-
tion 
37.8 (1.0) 38.2 (1.1) 0.022 
Data are reported as number (%) for categorical variables, and as mean and SD (±) for continuous variables.
P-values were calculated using unpaired t-test and Fisher’s exact test for the continues and categorical variables, respectively.
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As illustrated in table 8, there was a significant difference between the groups of patients with both OD and CAP 
and that of the patients with CAP alone, on the basis of all of the frailty parameters, except comorbidity where the 
difference was nonsignificant. 
Table 8: Frailty (difference adjusted for age and gender) 
 OD 
and 
CAP 
CAP Difference 
 (OD - no OD) 
95% CI 
P-
value 
Age-adjusted difference 
95% CI 
P-value 
Age 80.9 
(10.6) 
76.0 
(11.6) 
4.9 0.011   
Hand grip  12.7 
(11.1) 
19.6 
(12.1) 
-6.9 
(2.3; 11.5) 
0.004 -5.6 
(-10.1; -1.0) 
0.017 
Leg circumfer-
ence 
32.0 
(4.8) 
38.0 
(12.6) 
-6.0 
(-8.9; 3.0) 
<0.001 -5.8 
(-9.6; -1.9) 
0.003 
Barthel-20 12.4 
(6.4) 
18.2 (2.4) -5.7 
(-7.7; -3.8) 
<0.001 -5.5 
(-7.0; -4.1) 
<0.001 
Modified Rankin Scale 
No symptoms 2 
(3.8%) 
20 
(19.8%) 
    
No significant 
disability 
2 
(3.8%) 
23 
(22.8%) 
    
Slight disability 8 
(15.1%) 
25 
(24.8%) 
    
Moderate disa-
bility 
13 
(24.5%) 
26 
(25.7%) 
    
Moderately se-
vere disability 
18 
34.0% 
6 
5.9%) 
    
Severe disabil-
ity  
8 
(15.1%) 
0 (0%)     
Unknown 2 
(3.8%) 
1 (1.0%)  <0.001   
CCI 5.7 
(1.7) 
5.5  
(2.2) 
0.2 
(-0.5; 0.9) 
0.666 -0.1 
(-0.8; 0.6) 
0.785 
   Incident rate ratio  Age-adjusted relative 
risk 
 
Admission to a 
nursing home 
16 
(30.2%) 
3 (3.0%) 3.2 
(2.3; 4.4) 
<0.001 2.9 
(2.0; 4.1) 
<0.001 
Dementia 12 
(23.5%) 
4 (4.1%) 2.5 
(1.7; 3.7) 
<0.001 2.4 
(1.6; 3.6) 
<0.001 
Data are represented as number (%) for categorical variables and as mean and 95% CI for continuous variables. Independent 
t-test for continuous variables and relative risk is estimated by poisson regression. 
 
In the group of patients with both OD and CAP, 7 of the 53 patients (13.2%) died during hospitalisation, as illus-
trated in table 9, and in the group of patients with CAP, no patients died during hospitalisation (P < 0.001). Dur-
ing the 30 days after discharge, 10 patients of the surviving 46 with both OD and CAP (21.7%) died, as shown in 
table 9. In the group of patients with CAP alone, only 2 patients out of 101 (2.0%) died (P > 0.001).  
 
As shown in table 9, the group of patients who died during hospitalisation was characterised by a significantly 
higher mean age (8.6 years) and insignificantly lower Barthel-20 score and handgrip strength. No significant dif-
ferences were present between the two groups regarding these variables. 
 
 
31 
 
 
Table 9:  All causes of mortality during hospitalisation and within 30 days in patients with both OD and CAP 
 OD and CAP 
Dead 
N = 7 (13.2%) 
OD and CAP 
Alive 
N = 46 (86.8%) 
P-value 
Mortality during hospitalisation  
Mean age  88.3 (81.5; 95.2) 79.8 (76.6; 82.9) 0.045 
<70 y 0 (0%) 7 (15.2%) 0.575 
≥70 y 7 (100%) 39 (84.8%)  
Gender 
Male 4 (57.1%) 29 (63.0%) 1.000 
Barthel-20 
 9.8 (1.3; 18.3) 12.8 (10.9; 14.7) 0.296 
CURB65 
Mean 2.9 (2.0; 3.7) 2.3 (2.0; 2.5) 0.091 
0 0 (0%) 0 (0%)  
1 0 (0%) 6 (14.0%)  
2 3 (42.9%) 24 (55.8%)  
3 4 (57.1%) 13 (30.2%) 0.425 
CCI 4.8 (4.4; 5.3) 5.8 (5.2; 6.3) 0.224 
Dementia 1 (16.7%) 11 (24.4%) 0.565 
Handgrip 3.4 (1.2-18.4)) 8.7 (6.9-17.4) 0.423 
Circumference under leg 33.5 (30.0; 37.0) 31.8 (30.3; 33.3) 0.419 
Nursing home 4 (57.1%) 13 (28.3%) 0.139 
Dead within 30 days after dis-
charge 
 
N = 10 (21.7%) 
 
N = 36 (78.3%) 
 
Age 
Mean 80.8 (75.9; 83.0) 79.5 (75.9; 83.0) 0.736 
<70 y 1 (10%) 6 (16.7%)  
1.000 ≥70 y 9 (90%) 30 (83.3%) 
Gender    
Male 3 (30%) 26 (72.2%) 0.025 
Barthel-20 
 11.1 (6.2; 16.0) 13.2 (11.1; 15.4) 0.364 
CURB65 
Mean 2.2 (1.5; 2.9) 2.3 (2.0; 2.6) 0.815 
0 0 0  
1 3 (30%) 3 (9.1%) 0.090 
2 3 (30%) 21 (63.6%)  
3 4 (40%) 9 (27.3%)  
CCI 6.7 (5.2; 8.3) 5.5 (4.9; 6.1) 0.060 
Dementia 4 (40.0%) 7 (20.0%) 0.187 
Hand grip 8.0 (4.4-20.0) 9.4 (7.0-17.4) 0.616 
Circumference under leg 31.6 (28.1; 35.0) 31.9 (30.1; 33.7) 0.870 
Nursing home 3 (30%) 10 (27.8%) 0.589 
Data are represented as number (%) for categorical variables and as mean and 95% CI for continuous variables.  
P-values were calculated using unpaired t-test and Fisher’s exact test for the continuous and categorical variables. Handgrip 
is reported with a median (IQR) and analysed with the Wilcoxon rank-sum test.   
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As illustrated in figure 3 patients with CAP and OD are rehospitalised more frequently than patients with CAP. 
 
 
Figure 3: Rehospitalisation within 30 days after discharge 
 
 
 
As illustrated in table 10 the rehospitalised patients with both OD and CAP exhibited a significantly higher hand 
grip strength compared with that of the rehospitalised patients with CAP alone, but there were no significant dif-
ferences in any other variable. Patients with both CAP and OD are rehospitalised more frequently than those 
with CAP alone within 30 days after discharge. 
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Table 10: Characteristics of patients with both CAP and OD and patients with CAP alone rehospitalised within 30 
days after discharge. 
 OD and CAP 
Rehospitalised 
N = 10  
(21.7%) 
OD and 
CAP 
Not re-
hospitalised 
N = 36 
(78.3%) 
P-
value 
CAP 
Rehospi-
talised 
N = 15 
(14.9%) 
CAP 
Not rehospi-
talised 
N = 86 
(85.2%) 
P-
value 
Age 
Mean 74.1 (67.2 -87.6) 80.9 (77.5 -
89.0) 
0.174 74.7 (71.6-
81.7) 
77.4(70.8- 
84.6) 
0. 554 
<70 y 3 (30.0%) 4 (11.1%) 0.101 2 (13.3%) 21 (24.4%) 0.666 
≥70 y 7 (70.0%) 32 (88.9%)  13 (86.7%) 65 (75.6%)  
Gender 
Male 7 (70.0%) 22 (61.1%)  8 (53.3%) 43 (50.0%) 0.517 
Barthel-20 19 (11-19) 13 (7-17) 0.080 18 (16 - 
19) 
19 (17 - 20) 0.141 
CURB65 2 (2-2) 2 (2-3) 0.362 2 (1 - 2) 2 (1 - 2) 0.572 
0 0 (0%) 4 (0%) 0.759 0 (0%) 8 (9.7%) 0.475 
1 2 (22.2%) 4 (11.8%)  5 (35.7%) 27 (32.9%)  
2 5 (55.6%) 19 (55.9%)  7 (50.0%) 35 (42.7%)  
3 2 (22.2%) 11 (32.4%)  2 (14.3%) 12 (14.6%)  
CCI 6 (5 – 6) 5 (5 – 6) 0.895 5 (4 – 7) 5 (4 – 6) 0.579 
Dementia 0 (0%) 11 (30.6%) 0.059 1 (6.7%) 3 (3.7%) 0.495 
Handgrip strength 18.3  
(8.2-27) 
7.9  
(5.1- 12.1) 
0.017 19.2  
(16.2-20.7) 
17.9  
(11.6- 23.1) 
0.614 
Nursing home 1 (10.0%) 12 (33.3%) 0.240 0 (0%) 3 (3.5%) 1.000 
LOS (first hospitalisation) 
Days 7.2  
(5.3; 9.03) 
10.2  
(8.5; 12.0) 
0.020 8.5  
(5.3; 11.7) 
7.9  
(6.7; 9.1) 
0.727 
Data are represented as number (%) for categorical variables and as median (IQR) for continuous variables.  
P-values were calculated using unpaired t-test and Fisher’s exact test for the continuous and categorical variables, respec-
tively. 3 patients in the group of patients with CAP and OD who were rehospitalised and 1 patient in group of patients with 
CAP and OD who were not rehospitalised had incomplete CURB65.
 
 
The reasons for rehospitalisation were lung diseases and lung-related diseases for 80% of the patients with CAP 
and OD versus 63% of the patients with CAP alone.  
 
The patients with OD were followed for one year after discharge to describe the long-term consequences of OD.   
A group of 36 patients (72.2% male; mean age 80.9 years; SD ±10.5) were alive 31 days after discharge and 
were followed (figure 4). 
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Figure 4: Flowchart including patients with OD 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
As illustrated in table 11, this group of patients was characterised by a high mean age, 27.8% of them were living 
in nursing homes, and 42.9% of them had COPD. Approximately 70% of the patients were moderately to severely 
disabled, and the mean Barthel-20 score was 13.2. 
 
 
 
53  
patients had OD (34.4 %) 
170  
patients enrolled 
154 patients were included in the 
study 
 
 were included 
36 
patients for 1-year followup 
46 
patients were discharged (86.8%) 
( 
 
7 patients did not want to 
participate 
9 patients were not able to 
participate 
10 patients died within 30 
days after discharge  
(21.7 %) 
7 patients died during hospi-
talisation  
(13.2 %) 
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Table 11: Baseline data, demographic and clinical statistic for patients with OD and  
CAP 31 days after discharge. 
 N=36 
Gender  
Male 26 (72.2%) 
Age (mean) 80.9 (±10.5) 
<50 0 
50-69 6 
70-79 9 
80+ 1 
Point of origin  
House/apartment 26 (72.2%) 
Nursing home 10 (27.8%) 
CURB65  
Confusion (yes) 15 (44.1%) 
Urea (carbamide >7 Mmol/L) 24 (70.6%) 
Respiratory rate >30/min 5 (15.2%) 
 63 (8.8%) 
≥65 years 32 (88.9%) 
CURB65 (mean) 2.3 (0.872) 
0 0 (0%) 
1 3 (9.1%) 
2 21 (63.6%) 
3 7 (21.2%) 
4 1 (3.0%) 
5 1 (3.0%) 
CCI 5.5 (±1.6) 
Comorbidity  
Dementia 7 (20.0%) 
COPD 15 (42.9%) 
Diabetes 3 (8.6%) 
Hemiplegic 4 (11.4%) 
CRP 95.3(82.4) 
MRS  
No symptoms 1 (2.8%) 
No significant disability 2 (5.6%) 
Slight disability 6 (16.7%) 
Moderate disability 9 (25.0%) 
Moderately severe disability 11 (30.6%) 
Severe disability 5 (13.9%) 
Unknown 2 (5.6%) 
Barthel-20 13.2 (±6.1) 
Tooth status  
 No dentures 10 (27.8%) 
Dentures on upper jaw 6 (16.7%) 
Dentures on underjaw 0 (0%) 
Dentures 15 (41.7%) 
Unknown 5 (13.9%) 
Oral health  
 
 
36 
2 times per day 17 (47.2%) 
1 time per day 11 (30.6%) 
3-5 times per week 1 (2.8%) 
1-2 times per week 0 (0%) 
1 time per month 0 (0%) 
Weight 65.9 kg (±15.1) 
Height 169.2cm(9.6) 
BMI 22.7 (5.2) 
Waistline 101.2 (13.0) 
Circumference – upper arm 26.2 (4.5) 
Circumference – under leg 31.9 (5.1) 
Hand grip right 13.6 (12.0) 
Medication by discharge 9.1 (4.2) 
Temperature at hospitalisation 37.9 (0.9) 
Data are reported as number (%) for categorical variables, and as mean and SD (±) for continuous variable
 
As illustrated in table 12, 18 (50%) of the patients were rehospitalised 31-180 days after discharge, and this 
group of patients was characterised by a significantly higher Barthel-20 score, which indicates a higher func-
tional level. There were insignificant differences in all of the other parameters. The group of rehospitalised pa-
tients had a lower frequency of dementia, and the patients had a 2.5-day longer LOS in the hospital.  
In the period of 181-360 days, 17 (60.7%) were rehospitalised. The characteristics of these patients were a signif-
icantly higher Barthel-20 score and non-significant differences in the other parameters. The rehospitalised patients 
had a 1.7-day longer LOS than those who were not rehospitalised. 
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During 31-180 days after discharge, 8 (22.2%) patients died. These patients were significantly older (P=0.008), 
and more of them were male (P=0.076). As illustrated in table 13, there were no other significant or clinically 
relevant differences between the two groups.  
From 181-360 days after discharge, 13 (46.4%) patients died. The patients who died in this period after discharge 
had a significantly higher CCI (P=0.043) and a significantly weaker handgrip (P=0.027). There were no other 
relevant differences between the two groups. 
 
Table 12: All causes of rehospitalisation within 31-180 days and 181-360 days after discharge for patients with OD and CAP 
 31-180 days after discharge          181-360 days after discharge          
 Rehospitalised Not rehospital-
ised 
P-
value 
Rehospitalised Not rehospital-
ised 
P-value 
 N=18 (50.0%) N=18 (50.0%)  N=17 (60.7%) N=11 (39.3%)  
Age mean 80.6 (75.5; 85.7) 78.4 (72.9; 83.8) 0.528 78.5 (73.1; 84.0) 76.1 
(68.44;83.70) 
0.574 
<70 y 2 (11.1%) 4 (22.2%) 0.658 3 (17.7%) 3 (27.3%)  
≥70 y 16 (88.9%) 14 (77.8%)  14 (82.4%) 8 (72.7%) 0.653 
Gender 
Male 12 (66.7%) 14 (77.8%) 0.711 11 (64.7%) 7 (63.6%) 1.000 
Barthel-20 16.1 (14.1; 18.2) 10.5 (7.1; 14.0) 0.007 15.9 (13.5; 18.3) 9.7 (5.30; 14.10) 0.015 
CURB65 
Mean  2.5 (2.0; 3.0) 2.1 (1.8; 2.3) 0.124 2.4 (2.0; 2.9) 2.0 (1.58; 2.42) 0.137 
0 0 (0%) 0 (0%)  0 (0%) 0 (0%)  
1 1 (6.3%)) 2 (11.8%)  1 (7.1%)) 2 (18.2%)  
2 9 (56.3%) 12 (70.6%)  7 (50.0%) 7 (63.6%)  
3 4 (25.0%) 3 (17.7%)  6 (42.9%) 2 (18.2%)  
4 1 (6.3%) 0 (0%)  1 (7.1%) 0 (0%)  
5  1 (6.3%) 0 (0%) 0.683 0 (0%) 0 (0%) 0.707 
CCI 5.5 (4.6; 6.4) 5.5 (4.7; 6.2) 0.958 5.7 (4.6; 6.7) 4.9 (4.09; 5.73) 0.215 
Dementia 2 (11.1%) 5 (29.4%) 0.228 2 (12.5%) 4 (36.4%) 0.187 
Hand grip 8.5 (6.8-14.1) 13.7 (7-26) 0.632 8.5 (6.7 - 23.2) 7.3 (7.0 - 10.2) 0.991 
Nursing home 5 (27.8%) 5 (27.8%) 1.000 4 (23.5%) 4 (36.4%) 0.671 
MRS 
No symptoms 0 (0%) 1 (5.6%)  1 (5.9%) 0 (0%)  
No significant disability 1 (5.6%) 1 (5.6%)  1 (5.9%) 0 (0%)  
Slight disability 4 (22.2%) 2 (11.1%)  5 (29.4%) 1 (9.1%)  
Moderate disability 6 (33.3%) 3 (16.7%)  4 (23.5%) 3 (27.3%)  
Moderate severe disability 5 (27.8%) 6 (33.3%)  4 (23.5%) 3 (27.3%)  
Severe disability 1 (5.6%) 4 (22.2%)  1 (5.9%) 3 (27.3%)  
Unknown 1 (5.6%) 1 (5.6%) 0.668 1 (5.9%) 1 (9.1%) 0.654 
BMI 21.6 (16.6-27.2) 25.1 (21.4-26.7) 0.186 24.5 (21.4-25.6) 26.7 (25.1-28.0) 0.232 
LOS 10.7 (5.7; 14.9) 8.2 (4.8; 10.3) 0.261 9.2 (5.4; 14.9) 6.4 (4.4; 13.6) 0.541 
Data are represented as number (%) for categorical variables and as mean and 95% CI or SD (±) for continuous variables.  
P-values were calculated using unpaired t-test and Fisher’s exact test for the continuous and categorical variables. Handgrip and BMI is reported 
with a median (IQR) and analysed with the Wilcoxon rank-sum test.   
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The 1-year mortality rate for patients with both OD and CAP was 71.7% (38 patients out of 53) versus 19.8% (20 
patients out of 101) for the patients in this study with only CAP. 
 
Table 13: All causes of mortality within 31-180 days and 181-360 days after discharge for patients with OD 
and CAP 
 31-180 days after discharge 181-360 days after discharge 
 Alive Dead P-
value 
Alive Dead P-
value 
 N = 28 
(77.8%) 
N = 8  
(22.2%) 
 N = 15 
(53.6%) 
N = 13 
(46.4%) 
 
Age  
Mean 77.6  
(73.4; 81.7) 
86.2  
(81.2; 91.3) 
0.008 74.9  
(68.6; 81.3) 
80.6  
(89.7; 94.2) 
0.164 
<70 y 6 (21.4%) 0 (0%) 0.302 4 (26.7%) 2 (15.4%) 0.655 
≥70 y 22 (78.6%) 8 (100%)  11 (73.3%) 11 (86.6%)  
Gender       
Male 18 (64.3%) 8 (100%) 0.076 11 (73.3%) 7 (64.3%) 0.433 
Barthel-20 13.4  
(11.0; 115.8) 
12.8  
(6.7; 18.8) 
0.822 15.5  
(10.0; 17.1) 
13.2  
(9.4; 17.0) 
0.889 
CURB65  
Mean  2.2 (1.9; 2.5) 2.4 (1.5; 3.3) 0.744 2.1 (1.7; 2.5) 2.5 (2.0; 2.9) 0.192 
0 0 (0%) 0 (0%)  0 (0%) 0 (0%)  
1 3 (12.0%) 0 (0%)  3 (21.4%)) 0 (0%)  
2 14 (56.0%) 7 (87.5%)  7 (50.0%) 7 (63.6%)  
3 7 (28.0%) 0 (0%)  4 (28.6%) 4 (36.4%)  
4 1 (4.00%) 0 (0%)  0 (0%) 1 (9.1%)  
5 0 (0%) 1 (12.5%) 0.364 0 (0%) 0 (0%) 0.325 
CCI 5.4 (4.7; 6.1) 5.9 (4.7; 7.0) 0.400 4.7 (4.1; 5.4) 6.1 (4.9; 7.3) 0.043 
Dementia 6 (22.2%) 1 (12.5%) 1.000 2 (14.3%) 4 (30.8%) 0.385 
Handgrip 8.3 (7.0-17.4) 12.1 (10.8-16.2) 0.580 17.3 (8.3-26) 6.7 (2.2-7.3) 0.039 
Nursing home 8 (28.6%) 2 (25.0%) 1.000 4 (26.7%) 4 (30.8%) 1.000 
MRS       
No symptoms 1 (3.6%) 0 (0%)  1 (6.7%) 0 (0%)  
No significant 
disability 
1 (3.6%) 1 (12.5%)  0 (0%) 1 (7.7%)  
Slight disability 6 (21.4%) 0 (0%)  5 (33.3%) 1 (7.7%)  
Moderate disabil-
ity 
7 (25.0%) 2 (25.0%)  2 (13.3%) 5 (38.5%)  
Moderately severe 
disability 
7 (25.0%) 4 (50.0%)  5 (33.3%) 2 (15.4%)  
Severe disability 4 (14.3%) 1 (12.5%)  2 (13.3%) 2 (15.4%)  
Unknown 2 (7.1%) 0 (0%) 0.615 0 (0%) 2 (15.4%) 0.143 
BMI 25.1 (21.4-
27.2) 
17.9 (16.8-18.5) 0.225 25.1 (21.8-
27.2) 
21.4 (18.2-
27.4) 
0.764 
LOS 7.9 (4.6; 13.6) 9.8 (7.2; 12.4) 0.571 9.2 (4.8; 13.6) 6.4 (4.4; 14.9) 0.963 
Data are represented as number (%) for categorical variables and as mean and 95% CI or SD (±) for continuous variables. 
P-values were calculated using unpaired t-test and Fisher’s exact test for the continuous and categorical variables. Hand-
grip and BMI is reported with a median (IQR) and analysed with the Wilcoxon rank-sum test.   
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9. DISCUSSION 
The strength of these clinical studies is that the patients were consecutively included, and only a small group had to be 
excluded. The limitations of the studies are the relatively small sample sizes, which may have led to a type II statistical 
error. Another limitation is that the definition of CAP remains vague and unclear, and there is a risk that some of the 
patients hospitalised with aspiration pneumonia may be viewed as having a subtype of CAP 68,69.   
In Study 1 where the IG was mobilised within 24 hours the IG was compared with a historical CG. This design is not 
optimal, but performing a randomised controlled clinical study in one ward is a challenge70. The two groups were com-
parable in age, gender, severity of pneumonia (CURB65), CCI, time from admittance to initiation of antibiotic therapy, 
use of corticosteroids and they were all hospitalised with CAP in the same ward; however, the representation of COPD 
was higher in the CG than in the IG.  
 
Study 1 shows a clear tendency towards a shorter LOS (by 1.5 days) after an early, progressive, physiotherapeutic mo-
bilisation programme compared with standard care of patients with CAP.  
 
A randomised controlled study conducted in the US has reported a reduced LOS by 1.1 days for patients with CAP af-
ter an EM programme 38. Our findings are in accordance with this report, and they add to the sparse knowledge of the 
positive effect of early mobilisation on the LOS for patients with CAP.  
 
LOS is related to the systematically evaluated basic mobility status of patients throughout their admittance, and there is 
an association between the CURB65 score and the LOS for both groups. Of interest, patients with a CURB65 score of 
2 appear to benefit the most from EM, as indicated by a reduction in the LOS of 2.67 days compared with the CG. This 
finding appears to correspond to the findings for patients in the EM group with a Pneumonia Severity Index score of 3 
in a study by Mundy et al. 38. However, this comparison should be interpreted with caution, owing to the different score 
systems used. Nonetheless, it seems that the patients who benefit the most from EM are those classified with a low to 
medium severity index.  The study also indicated that patients with a low prehospital NMS tends to have a longer LOS 
than those with a higher functional level.  
 
Another explanation of the reduction of the LOS in the present study may be that the physiotherapist in cooperation 
with the patient sets goals for the treatment.  A review of the literature discussing goal-setting indicates that some stud-
ies demonstrate positive effects of goal-setting, although other studies are methodologically weak and have shown no 
evidence of the effect of goal-setting 71. However, the design of this study makes it impossible to separate the effect of 
EM from the effect of goal-setting.  
 
The mortality during hospitalisation in a study by Mundy et al. 38 was lower in the IG than in the CG; however, as in 
the present study, no significant difference was seen for mortality during hospitalisation or 30 days after admission.  
 
The frequency of rehospitalisation was higher in the IG, even though it was not significant, and the difference was pri-
marily due to patients being rehospitalised for diseases not related to the lungs.  
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Study II documents the prevalence of OD in patients with CAP and OD was observed in 37.1% of the patients over 70 
years. This study found that the risk factors for OD and CAP are increased age, severe CAP, dementia, poor dental sta-
tus and oral hygiene, poor level of mobility before hospitalisation, decreased hand grip strength, and living in a nursing 
home. Other studies have also documented this link between people living in a nursing home and OD and between in-
dependent people and OD 72. It is well known that frailty correlates with vulnerability, poor outcomes, and death 73,74, 
as confirmed by the results of this study. In this study, frailty was measured by the following parameters: functional 
capacity, handgrip strength, dementia, and admission from a nursing home. There are some available frailty tools, such 
as the Clinical Frailty Scale, Frailty Index, Comprehensive Geriatric Assessment, Vulnerable Elders Survey-13, Gro-
ningen Frailty Indicator, and Geriatric 8 75. However, multiple studies have found that these tools are not suitable for 
routine use at the bedside. The diagnostic value of these instruments is poor, and their clinical value may be weak 76,77. 
 
The videofluoroscopy (VFES) and fiberoptic endoscopic evaluation of swallowing (FEES) are objective assessments of 
the swallow function. In our clinical setting, these were not possible, so we used V-VST because studies have shown a 
strong correlation between videofluoroscopy and V-VST 64 and because an OD-screening protocol with a standardised 
bedside screening decreases the risk of CAP. V-VST uses a decrease in the oxygen saturation ≥3% to detect silent aspi-
ration.  A smaller fall in oxygen saturation is not a reliable indicator of silent aspiration78. Nonetheless, a bedside test 
combined with pulse oximetry is recommended 79. Pharyngeal residue is one of the signs of swallowing disorders, and 
although it can be visualised by videofluoroscopy, it is impossible to visualise in bedside screening. V-VST is recom-
mended in more reviews 79,80 but has not yet been validated in Denmark. Silent aspiration is prevalent in patients with 
pneumonia, but it is detectable only with VFES or FEES. OD may be underestimated because it was assessed with a 
bedside test, not with VFES or FEES.  
 
The group of patients with both OD and CAP has a higher rehospitalisation rate than the group of patients with CAP 
alone. It is well known that patients with OD have a higher frequency of rehospitalisation 81. Patients with both OD and 
CAP who are rehospitalised compared with those who are not readmitted have a significantly stronger handgrip 
(P=0.004). The group of patients rehospitalised with both OD and CAP compared with the rehospitalised patients with 
CAP alone is characterised by non-significant differences of decreased age, higher Barthel-20 score, less dementia and 
origins from nursing homes. There may be multiple explanations for these findings: 1) patients living in their own resi-
dence may have more difficulty in changing their eating habits than those living in nursing homes and 2) doctor delay, 
which in this context implies that doctors and nurses do not hospitalise elderly people with CAP alone but instead let 
them stay in their nursing homes during treatment.      
Patients with both OD and CAP had significantly increased in-hospital, 30-day and 1-year mortality rates compared 
with those of patients with CAP alone. A Danish multicentre study including elderly citizens admitted with CAP 14 has 
reported an in-hospital mortality of 11.5%. In our study, the group with both CAP and OD showed an in-hospital mor-
tality of 13.5% versus a non-OD value of 0%. The multicentre study has reported a 30-day mortality of 8.6%. The pre-
sent study had a 30-day mortality for patients with both CAP and OD of 19.2% versus a value for non-OD patients of 
2.0%. The one-year mortality is high in patients with OD 82,83, and this study confirms these results with a 1-year mor-
tality of 71.7% for patients with both CAP and OD. 
   
The relatively high prevalence of OD underlines the necessity of awareness about OD in patients hospitalised with 
CAP and indicates the need for systematic screening for OD, as is also recommended in national and international 
guidelines and recommendations 47,84.  
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10. CONCLUSION 
An EM programme compared with standard care reduces the LOS for patients with CAP. Patients with CAP who are 
mobilised within 24 hours after hospitalisation are discharged 1.5 days earlier than those not mobilised within 24 hours. 
We found no significant difference in the in-hospital and short-term mortality rates or in the short-term pulmonary-
related rehospitalisation rate between the two groups. 
More than one-third of all patients hospitalised with CAP had OD. Compared with the patients with CAP alone, the 
patients with both CAP and OD showed significant differences in the parameters related to frailty. This study demon-
strates that patients with both OD and CAP have a high frequency of rehospitalisation and that the long-term mortality 
is very high (71.7%) for patients hospitalised with both CAP and OD.  
The results of the studies suggest that progressive EM shall be part of the standard treatment programme offered to pa-
tients who are hospitalised with CAP and that a systematic investigation of OD in elderly patients with CAP shall be 
implemented in the guidelines. 
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11. PERSPECTIVES 
These studies have made it clear that it is appropriate to expand the interdisciplinary approach towards the treatment of 
CAP with a systematic intervention by physiotherapists and occupational therapists. It has been confirmed that early 
mobilisation within 24 hours can reduce the LOS, especially in patients with a relatively high level of functioning prior 
to admission and with a moderately severe CAP. This group of patients in particular should be systematically mobi-
lised as soon as possible after hospitalisation and with an individual approach. Because the majority of patients in Den-
mark are admitted to the emergency room, mobilisation should occur even there. It is relevant to study whether the ef-
fects of early mobilisation may be even greater, for example, within 12 hours after hospitalisation. 
In Denmark, there has been no focus on the systematic screening for OD in patients with CAP. This study shows that 
approximately one out of three patients with CAP has OD, and those with OD are often frail and their LOS is 2 days 
longer than that for patients with CAP alone. This knowledge provides a basis for a systematic screening for OD very 
early after admission to uncover whether such a protocol may reduce hospitalisation time and the number of readmis-
sions. At the North Denmark Regional Hospital, in the spring of 2017, we will launch a research project wherein, for 6 
months, we will perform OD screening in all patients admitted in the emergency room. We expect to include 5,500 pa-
tients, and with this project, we will be able to predict the prevalence in the population and in subpopulations, e.g., pa-
tients with COPD, diabetes or alcoholism. That study should also demonstrate the importance of the awareness of OD 
in an acute hospital. Another initiative is a video about the signs of OD and the interventions to reduce the conse-
quences of OD. This video is an obligatory introduction to all staff with patient contact. A multidisciplinary focus on 
OD is important, and in North Denmark Regional Hospital, the kitchen staff is continually developing food for this 
group of patients on the basis of the contributions of dieticians as well as nurses, physiotherapists and doctors.  
The study of OD has attracted attention from other hospitals, but, especially from municipalities where there is aware-
ness of the relation between OD and a high risk of CAP and hospital admissions. In Denmark the municipalities are 
financing a part of the costs of the hospitalisations. In spring 2017 we will present the total financial burden in patients 
with OD and CAP compared to patients with CAP. The calculation will include the total costs calculated for 12 months 
prior to admission to 3 months after discharge. 
FEES has been implemented as a routine assessment in critically ill patients at risk to develop aspiration following ex-
tubation. In 2017 we plan to implement FEES as a possible assessment for e.g. patients with signs of silent aspiration.   
 
In general, the awareness of OD in patients other than neurological patients has increased significantly in Denmark 
during the past 2-3 years. In autumn 2016, the Danish Society of Dysphagia was founded. The board represents a mul-
tidisciplinary and intersectoral group, and the undersigned was selected as chairman of the society. 
 
The results of this study support the conclusion that systematic early mobilisation and systematic screening for OD in 
elderly patients with CAP can optimise treatment outcomes. Because only limited resources would be required in con-
junction with other treatments, it would be appropriate to include early mobilisation and screening for OD in the guide-
lines for CAP. 
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